mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.013 |
0.7 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
regorafenib |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.015 |
0.7 |
mRNA |
serdemetan:SCH-529074 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.014 |
0.7 |
mRNA |
Teniposide |
CTRPv2 |
pan-cancer |
AAC |
0.015 |
0.7 |
mRNA |
ibrutinib |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.7 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.7 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
0.014 |
0.7 |